Keywords: Ono Pharma, Tioga, asimadoline

Ono Pharma gets rights to Tioga’s asimadoline in Japan, South Korea and Taiwan

Article | 02 September 2009

US firm Tioga Pharmaceuticals has announced an exclusive license agreement under which Japanese drugmaker Ono Pharmaceuticals has licensed rights to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in